Gainers
Netcapital Inc. (NASDAQ: NCPL) shares rose 91.3% to $2.65 in pre-market trading following Q2 results. Netcapital posted Q2 earnings of $0.04 per share on sales of $1.78 million.
Magenta Therapeutics Inc (NASDAQ:MGTA) highlighted updated data from the ongoing MGTA-117 Phase 1/2 dose-escalation trial at the American Society of Hematology…
– MGTA-117 preliminary clinical results from 15 patients across three dose-escalation cohorts of the ongoing Phase 1/2 clinical trial shows single-agent activity with no dose-limiting toxicities; transition to
Magenta Therapeutics (NASDAQ:MGTA) reported quarterly losses of $(0.27) per share. This is a 10 percent increase over losses of $(0.30) per share from the same period last year.